<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-OM3LJPKL</identifier><date>2025</date><creator>Demirkesen, Cuyan</creator><creator>Okan, Gökhan</creator><relation>documents/doc/O/URN_NBN_SI_doc-OM3LJPKL_001.pdf</relation><relation>documents/doc/O/URN_NBN_SI_doc-OM3LJPKL_001.txt</relation><format format_type="volume">34</format><format format_type="type">article</format><format format_type="issue">iss. 3</format><format format_type="extent">str. 157-158</format><identifier identifier_type="DOI">10.15570/actaapa.2025.28</identifier><identifier identifier_type="ISSN">1318-4458</identifier><identifier identifier_type="COBISSID_HOST">260108547</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-OM3LJPKL</identifier><language>eng</language><publisher publisher_location="Ljubljana">Slovene Welding Society</publisher><source>Acta dermatovenerologica Alpina, Pannonica et Adriatica</source><rights>InC</rights><subject language_type_id="slv">B-celica</subject><subject language_type_id="eng">B-cell</subject><subject language_type_id="eng">eosinophil</subject><subject language_type_id="slv">eozinofil</subject><subject language_type_id="slv">imikvimod</subject><subject language_type_id="eng">imiquimod, eosinophil</subject><subject language_type_id="eng">pseudolymphoma</subject><subject language_type_id="slv">psevdolimfom</subject><title>Cutaneous B-cell pseudolymphoma treated with imiquimod</title></Record>